Stay updated on Nivolumab and Axitinib in RCC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Axitinib in RCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Axitinib in RCC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page now displays revision v3.5.4 instead of v3.5.3, indicating an updated version of the page template or documentation.
    Difference
    0.1%
    Check dated 2026-05-15T07:49:29.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page revision/version label has been updated from v3.5.2 to v3.5.3, indicating a platform release rather than a change to the clinical trial record content.
    Difference
    0.1%
    Check dated 2026-04-24T05:23:55.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:13:15.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    A new revision label v3.5.0 was added and the previous label v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-19T04:39:58.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-11T23:49:24.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    An administrative update adds a new revision tag (v3.4.2) and removes older notices (lapse in government funding notice and v3.4.1), with no impact on study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:27:12.000Z thumbnail image

Stay in the know with updates to Nivolumab and Axitinib in RCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Axitinib in RCC Clinical Trial page.